"Unnamed: 0","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-198933","R-HSA-198933","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","25/192","134/10891",5.01641543010903e-19,2.24735411268885e-16,1.94320092450539e-16,"B2M/CD160/CD300A/CD300C/CD300E/CD300LF/COLEC12/CRTAM/CXADR/HLA-E/ICAM1/ICAM3/KLRB1/LAIR1/LILRA5/LILRB4/NCR3LG1/NECTIN2/NPDC1/OSCAR/PILRA/PILRB/SIGLEC1/SIGLEC10/VCAM1",25
"R-HSA-5669034","R-HSA-5669034","TNFs bind their physiological receptors","11/192","29/10891",1.00684121638561e-12,2.25532432470377e-10,1.95009246121003e-10,"CD27/EDA2R/TNFRSF13B/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF8/TNFRSF9/TNFSF13B",11
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","18/192","125/10891",5.61651769484318e-12,8.38733309096582e-10,7.25220530421857e-10,"CHRDL1/CKAP4/CSF1/CST3/FGF23/FSTL1/FSTL3/IGFBP2/IGFBP4/IGFBP6/IGFBP7/IL6/MSLN/SCG2/SHISA5/SPP1/TIMP1/VCAN",18
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","12/192","47/10891",1.94654469899684e-11,2.18013006287646e-09,1.88507486639694e-09,"CCL20/CD80/CSF1/FCER2/ICAM1/IL10/IL10RB/IL6/TIMP1/TNF/TNFRSF1A/TNFRSF1B",12
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","16/192","108/10891",5.72885756449853e-11,5.13305637779068e-09,4.43835701839044e-09,"CHRDL1/CKAP4/CSF1/CST3/FGF23/FSTL1/FSTL3/IGFBP4/IGFBP7/IL6/MSLN/SCG2/SHISA5/SPP1/TIMP1/VCAN",16
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","15/192","102/10891",2.60074924148185e-10,1.94189276697311e-08,1.67908021204442e-08,"CD27/EDA2R/LTBR/TNF/TNFRSF11A/TNFRSF12A/TNFRSF13B/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF8/TNFRSF9/TNFSF13B",15
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","22/192","300/10891",1.42005519949974e-08,9.08835327679836e-07,7.85835057768279e-07,"ADAM8/ADAM9/AGRN/BSG/CEACAM6/COL18A1/COL6A3/CTSL/EFEMP1/HSPG2/ICAM1/ICAM3/JAM2/LTBP2/MMP12/MMP3/MMP7/SDC1/SPP1/TIMP1/VCAM1/VCAN",22
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","28/192","482/10891",2.31016035551816e-08,1.29368979909017e-06,1.11860396161932e-06,"ADA2/ADAM8/B2M/B4GALT1/BST2/CD14/CD300A/CD55/CD59/CD93/CEACAM6/CKAP4/CLEC4D/CLEC5A/CST3/CTSZ/LAIR1/LCN2/NPC2/OSCAR/PIGR/PLAUR/PSAP/PTPRN2/RETN/RNASET2/SIRPB1/TNFRSF1B",28
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","27/192","473/10891",6.08329222100092e-08,3.02812768334268e-06,2.61830589161209e-06,"CCL20/CD80/CSF1/FCER2/HAVCR2/HGF/ICAM1/IFNL1/IL10/IL10RB/IL12RB1/IL15/IL15RA/IL18BP/IL1RL1/IL2RA/IL4R/IL6/LCN2/LGALS9/MMP3/SDC1/TIMP1/TNF/TNFRSF1A/TNFRSF1B/VCAM1",27
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","12/192","108/10891",4.06646600266544e-07,1.82177676919412e-05,1.57522051471672e-05,"FCER2/HGF/ICAM1/IL10/IL4R/IL6/LCN2/MMP3/TIMP1/TNF/TNFRSF1B/VCAM1",12
"R-HSA-9694614","R-HSA-9694614","Attachment and Entry","6/192","19/10891",6.22352441132901e-07,2.53467176025036e-05,2.19163347690821e-05,"AGRN/CTSL/HAVCR1/HSPG2/NRP1/SDC1",6
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","13/192","137/10891",8.36666369651092e-07,3.12355444669741e-05,2.70081775466317e-05,"ANGPT2/BSG/CD48/CD74/CEACAM6/CXADR/ESAM/JAM2/MERTK/SDC1/THBD/TNFRSF10A/TNFRSF10B",13
"R-HSA-216083","R-HSA-216083","Integrin cell surface interactions","10/192","85/10891",2.28003516066969e-06,7.85735193830784e-05,6.79395092410076e-05,"AGRN/BSG/COL18A1/COL6A3/HSPG2/ICAM1/ICAM3/JAM2/SPP1/VCAM1",10
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","12/192","140/10891",6.50164125047439e-06,0.00020805252001518,0.00017989503610335,"ADAM8/ADAM9/BSG/COL18A1/COL6A3/CTSL/HSPG2/MMP12/MMP3/MMP7/SPP1/TIMP1",12
"R-HSA-9772572","R-HSA-9772572","Early SARS-CoV-2 Infection Events","6/192","38/10891",4.79146252905581e-05,0.00143105014201134,0.00123737418294213,"AGRN/CTSL/HAVCR1/HSPG2/NRP1/SDC1",6
"R-HSA-3560782","R-HSA-3560782","Diseases associated with glycosaminoglycan metabolism","6/192","41/10891",7.46876106567779e-05,0.00209125309838978,0.00180822636326936,"AGRN/B4GALT1/HSPG2/OGN/SDC1/VCAN",6
"R-HSA-1442490","R-HSA-1442490","Collagen degradation","7/192","64/10891",0.00012604586480686,0.00332167926079261,0.00287212868414399,"ADAM9/COL18A1/COL6A3/CTSL/MMP12/MMP3/MMP7",7
"R-HSA-5676594","R-HSA-5676594","TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway","4/192","18/10891",0.00023601774009186,0.00587421930895311,0.00507921218443314,"LTBR/TNFRSF11A/TNFRSF12A/TNFSF13B",4
"R-HSA-5694530","R-HSA-5694530","Cargo concentration in the ER","5/192","33/10891",0.00025682068819712,0.00605556149012157,0.00523601181476677,"AREG/CD59/CTSZ/FOLR1/TGFA",5
"R-HSA-3560783","R-HSA-3560783","Defective B4GALT7 causes EDS, progeroid type","4/192","20/10891",0.00036351804743512,0.00740254932958793,0.00640070054813994,"AGRN/HSPG2/SDC1/VCAN",4
"R-HSA-3560801","R-HSA-3560801","Defective B3GAT3 causes JDSSDHD","4/192","20/10891",0.00036351804743512,0.00740254932958793,0.00640070054813994,"AGRN/HSPG2/SDC1/VCAN",4
"R-HSA-4420332","R-HSA-4420332","Defective B3GALT6 causes EDSP2 and SEMDJL1","4/192","20/10891",0.00036351804743512,0.00740254932958793,0.00640070054813994,"AGRN/HSPG2/SDC1/VCAN",4
"R-HSA-449836","R-HSA-449836","Other interleukin signaling","4/192","24/10891",0.00075450005092606,0.0146963488180381,0.0127073692787547,"CSF1/IFNL1/IL10RB/SDC1",4
"R-HSA-1236977","R-HSA-1236977","Endosomal/Vacuolar pathway","3/192","11/10891",0.00080184303821195,0.0149677367132898,0.0129420279851754,"B2M/CTSL/HLA-E",3
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","5/192","44/10891",0.00100471044500174,0.017794418883058,0.0153861516658021,"HAVCR2/IL15/IL15RA/IL2RA/LGALS9",5
"R-HSA-1971475","R-HSA-1971475","A tetrasaccharide linker sequence is required for GAG synthesis","4/192","26/10891",0.00103271181017748,0.017794418883058,0.0153861516658021,"AGRN/HSPG2/SDC1/VCAN",4
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","5/192","45/10891",0.0011143481662416,0.0184899251287495,0.0159875292466631,"B2M/CD300E/CLEC5A/HLA-E/SIRPB1",5
"R-HSA-3656237","R-HSA-3656237","Defective EXT2 causes exostoses 2","3/192","14/10891",0.00170121723859521,0.026280873203126,0.022724063295936,"AGRN/HSPG2/SDC1",3
"R-HSA-3656253","R-HSA-3656253","Defective EXT1 causes exostoses 1, TRPS2 and CHDS","3/192","14/10891",0.00170121723859521,0.026280873203126,0.022724063295936,"AGRN/HSPG2/SDC1",3
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","5/192","51/10891",0.00196764402203526,0.0293834840623932,0.0254067719336483,"EFNA1/EFNA4/EPHA2/EPHB4/EPHB6",5
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","6/192","78/10891",0.00249016241982008,0.0359482094932046,0.031083038283598,"AREG/CD28/CD80/FGF23/HGF/TGFA",6
"R-HSA-1592389","R-HSA-1592389","Activation of Matrix Metalloproteinases","4/192","33/10891",0.00256772924951461,0.0359482094932046,0.031083038283598,"COL18A1/MMP3/MMP7/TIMP1",4
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","7/192","106/10891",0.00265975600708154,0.0361082027628039,0.0312213783287402,"AREG/CD28/CD80/FGF23/HGF/IL1RL1/TGFA",7
"R-HSA-140534","R-HSA-140534","Caspase activation via Death Receptors in the presence of ligand","3/192","17/10891",0.00305677394700382,0.0402774920075797,0.0348264028636967,"CD14/TNFRSF10A/TNFRSF10B",3
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","8/192","143/10891",0.00378152065075819,0.0473314181279038,0.0409256622910446,"AGRN/B4GALT1/HSPG2/OGN/SDC1/SPON1/SPON2/VCAN",8
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","7/192","113/10891",0.00380341752813513,0.0473314181279038,0.0409256622910446,"AREG/CD28/CD80/FGF23/HGF/IL1RL1/TGFA",7
